Abstract
Cardiovascular diseases (CVD) are the main object of morbidity and death in the world. There are different triggers of CVD, but atherosclerosis and/or hypertension are the most usual. CVD risk factors are used as prognosticators of disease process, while the biomarkers that envisage cardiovascular risk have an important biological basis. The integration of CVD risk factors and new biomarkers can improve CVD risk stratification and disease management. The identification of microparticles (MPs) in body fluids has opened new perspectives in diagnosis, prognosis and therapy of CVD pathogenesis. MPs are submicron vesicles released from a diversity of cell types with pleiotropic biological effects on signaling among cells. They are correlated with disease state and play a major role in atherosclerosis associated with inflammation, thrombosis as well as in CVD development and progression. This review reveals many sides of MPs as risk factors, biomarkers, novel forms of intercellular communication, non-invasive potential diagnostic tools and discusses their positive and negative impact on CVD.
Keywords: Biomarkers, cardiovascular disease, diagnostic tools, microparticles.
Current Stem Cell Research & Therapy
Title:Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease
Volume: 12 Issue: 2
Author(s): Nicoleta Alexandru, Ana Costa, Alina Constantin, Daniel Cochior and Adriana Georgescu
Affiliation:
Keywords: Biomarkers, cardiovascular disease, diagnostic tools, microparticles.
Abstract: Cardiovascular diseases (CVD) are the main object of morbidity and death in the world. There are different triggers of CVD, but atherosclerosis and/or hypertension are the most usual. CVD risk factors are used as prognosticators of disease process, while the biomarkers that envisage cardiovascular risk have an important biological basis. The integration of CVD risk factors and new biomarkers can improve CVD risk stratification and disease management. The identification of microparticles (MPs) in body fluids has opened new perspectives in diagnosis, prognosis and therapy of CVD pathogenesis. MPs are submicron vesicles released from a diversity of cell types with pleiotropic biological effects on signaling among cells. They are correlated with disease state and play a major role in atherosclerosis associated with inflammation, thrombosis as well as in CVD development and progression. This review reveals many sides of MPs as risk factors, biomarkers, novel forms of intercellular communication, non-invasive potential diagnostic tools and discusses their positive and negative impact on CVD.
Export Options
About this article
Cite this article as:
Alexandru Nicoleta, Costa Ana, Constantin Alina, Cochior Daniel and Georgescu Adriana, Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease, Current Stem Cell Research & Therapy 2017; 12 (2) . https://dx.doi.org/10.2174/1574888X11666151203224058
DOI https://dx.doi.org/10.2174/1574888X11666151203224058 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Merging Traditional Chinese Medicine with Modern Drug Discovery Technologies to Find Novel Drugs and Functional Foods
Current Drug Discovery Technologies Management of Erectile Dysfunction: An Under-Recognition of Hypertension
Current Pharmaceutical Design Winning a Won Game: Caffeine Panacea for Obesity Syndemic
Current Neuropharmacology Vitamin D: A Regulator of Metabolism and Inflammation
Current Nutrition & Food Science Secondary Metabolites in the Treatment of Diabetes Mellitus: A Paradigm Shift
Current Drug Metabolism The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?
Current Vascular Pharmacology Prevalence of Cardiovascular and Metabolic Events in Patients Prescribed Clozapine: A Retrospective Observational, Clinical Cohort Study
Current Drug Safety Role of Vascular Endothelial Growth Factor in Kidney Disease
Current Vascular Pharmacology Resveratrol: A Therapeutic Approach to Neurodegenerative Diseases and Aging
Mini-Reviews in Organic Chemistry Bariatric Surgery and it Effects on the Respiratory System
Current Respiratory Medicine Reviews Systemic Lupus Erythematosus: Symptoms and Signs at Initial Presentations
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Dosing of Antibiotics in Critically Ill Patients Undergoing Renal Replacement Therapy
Current Pharmaceutical Biotechnology Targeting MCP-1 to Reduce Vascular Complications of Obesity
Recent Patents on Cardiovascular Drug Discovery Vascular Endothelial Primary Cilia: Mechanosensation and Hypertension
Current Hypertension Reviews Hepatocyte Growth Factor (HGF), an Endogenous Pulmotrophic Regulator, for the Rescue of Acute and Chronic Lung Diseases
Current Signal Transduction Therapy Pharmacogenomics in Psychiatry: Implications for Practice
Recent Patents on Biotechnology The Detection of Adverse Events in Randomized Clinical Trials: Can we Really Say New Medicines are Safe?
Current Drug Safety Potential Therapeutic Targets in Cirrhotic Cardiomyopathy
Cardiovascular & Hematological Disorders-Drug Targets The Resurgence of Aldosterone in Hypertension and Cardiovascular Disease
Current Hypertension Reviews Nocturnal Hypertension and Chronic Kidney Disease
Current Hypertension Reviews